Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270.

[1]  S. Smiley.  Immune defense against pneumonic plague , 2008, Immunological reviews.

[2]  J. Bliska,et al.  Vaccination of Mice with a Yop Translocon Complex Elicits Antibodies That Are Protective against Infection with F1−Yersinia pestis , 2008, Infection and Immunity.

[3]  Ruifu Yang,et al.  A new purification strategy for fraction 1 capsular antigen and its efficacy against Yersinia pestis virulent strain challenge. , 2008, Protein expression and purification.

[4]  É. Carniel,et al.  Oral Vaccination against Bubonic Plague Using a Live Avirulent Yersinia pseudotuberculosis Strain , 2008, Infection and Immunity.

[5]  S. Smiley.  Current challenges in the development of vaccines for pneumonic plague , 2008, Expert review of vaccines.

[6]  R. Steinman,et al.  Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC‐205/CD205‐positive mouse dendritic cells , 2008, European journal of immunology.

[7]  R. Titball,et al.  Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague. , 2007, Vaccine.

[8]  A. Philipovskiy,et al.  Vaccination with Live Yersinia pestis Primes CD4 and CD8 T Cells That Synergistically Protect against Lethal Pulmonary Y. pestis Infection , 2006, Infection and Immunity.

[9]  O. Schneewind,et al.  Immunogenicity and Protective Immunity against Bubonic Plague and Pneumonic Plague by Immunization of Mice with the Recombinant V10 Antigen, a Variant of LcrV , 2006, Infection and Immunity.

[10]  D. N. Rao,et al.  Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery. , 2006, Vaccine.

[11]  D. Reed,et al.  Respiratory immunity is an important component of protection elicited by subunit vaccination against pneumonic plague. , 2006, Vaccine.

[12]  G. Lowell,et al.  Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection. , 2006, Vaccine.

[13]  Bali Pulendran,et al.  Translating Innate Immunity into Immunological Memory: Implications for Vaccine Development , 2006, Cell.

[14]  S. Marillonnet,et al.  Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Kiera N. Berggren,et al.  Cell-Mediated Protection against Pulmonary Yersinia pestis Infection , 2005, Infection and Immunity.

[16]  Stephen Wessels,et al.  Microbial Cell Factories BioMed Central Review Ensuring safety of DNA vaccines , 2005 .

[17]  O. Schneewind,et al.  LcrV Plague Vaccine with Altered Immunomodulatory Properties , 2005, Infection and Immunity.

[18]  J. Clements,et al.  Protection against Aerosolized Yersinia pestis Challenge following Homologous and Heterologous Prime-Boost with Recombinant Plague Antigens , 2005, Infection and Immunity.

[19]  W. Swietnicki,et al.  Yersinia pestis Yop secretion protein F: purification, characterization, and protective efficacy against bubonic plague. , 2005, Protein expression and purification.

[20]  Jyl S Matson,et al.  Immunization of mice with YscF provides protection from Yersinia pestis infections , 2005, BMC Microbiology.

[21]  H. Flick-Smith,et al.  Human Immune Response to a Plague Vaccine Comprising Recombinant F1 and V Antigens , 2005, Infection and Immunity.

[22]  S. Riedel.  Plague: From Natural Disease to Bioterrorism , 2005, Proceedings.

[23]  J. Clements,et al.  Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens. , 2005, Vaccine.

[24]  R. Titball,et al.  Protective efficacy of a recombinant plague vaccine when co-administered with another sub-unit or live attenuated vaccine. , 2005, FEMS immunology and medical microbiology.

[25]  H. P. Sørensen,et al.  Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli , 2005 .

[26]  Y. Tsutsumi,et al.  Development of novel drug delivery system (DDS) technologies for proteomic-based drug development. , 2004, Biological and Pharmaceutical Bulletin.

[27]  R. Titball,et al.  A Salmonella enterica serovar Typhi vaccine expressing Yersinia pestis F1 antigen on its surface provides protection against plague in mice. , 2004, Vaccine.

[28]  R. Titball,et al.  Yersinia pestis (plague) vaccines , 2004, Expert opinion on biological therapy.

[29]  Shixia Wang,et al.  A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague , 2004, Vaccine.

[30]  Donna J. Freeman,et al.  Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen. , 2004, Vaccine.

[31]  C. Bourgeois,et al.  Mini‐review CD4 T cells are required for CD8 T cell memory generation , 2003, European journal of immunology.

[32]  E. Williamson,et al.  Protective efficacy of a fully recombinant plague vaccine in the guinea pig. , 2003, Vaccine.

[33]  D. Godson,et al.  The effectiveness and limitations of immune memory: understanding protective immune responses. , 2003, International journal for parasitology.

[34]  A. Shafferman,et al.  Effective Protective Immunity to Yersinia pestis Infection Conferred by DNA Vaccine Coding for Derivatives of the F1 Capsular Antigen , 2003, Infection and Immunity.

[35]  R. Titball,et al.  A single dose sub-unit vaccine protects against pneumonic plague. , 2000, Vaccine.

[36]  E. Williamson,et al.  Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains. , 2000, Vaccine.

[37]  J. Eyles,et al.  Protection studies following bronchopulmonary and intramuscular immunisation with yersinia pestis F1 and V subunit vaccines coencapsulated in biodegradable microspheres: a comparison of efficacy. , 2000, Vaccine.

[38]  D. N. Rao,et al.  Identification of immunodominant epitope of F1 antigen of Yersinia pestis. , 2000, FEMS immunology and medical microbiology.

[39]  R. Titball,et al.  An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model , 1999, Clinical and experimental immunology.

[40]  A. Friedlander,et al.  Immune Response to Yersinia Outer Proteins and Other Yersinia pestis Antigens after Experimental Plague Infection in Mice , 1999, Infection and Immunity.

[41]  S. Welkos,et al.  Protective Efficacy of RecombinantYersinia Outer Proteins against Bubonic Plague Caused by Encapsulated and Nonencapsulated Yersinia pestis , 1999, Infection and Immunity.

[42]  S. Chanteau,et al.  Field evaluation of an immunoglobulin G anti-F1 enzyme-linked immunosorbent assay for serodiagnosis of human plague in Madagascar , 1997, Clinical and diagnostic laboratory immunology.

[43]  R. Titball,et al.  A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague. , 1997, Vaccine.

[44]  Y. Nedialkov,et al.  Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide: amplification of interleukin-10 , 1997, Infection and immunity.

[45]  R. Perry,et al.  Yersinia pestis--etiologic agent of plague , 1997, Clinical microbiology reviews.

[46]  R. Titball,et al.  A new improved sub-unit vaccine for plague: the basis of protection. , 1995, FEMS immunology and medical microbiology.

[47]  V. Motin,et al.  Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization , 1995, Infection and immunity.

[48]  R. Brubaker,et al.  Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha , 1993, Infection and immunity.

[49]  R. Brubaker,et al.  Roles of V antigen in promoting virulence and immunity in yersiniae. , 1984, Journal of immunology.

[50]  H. Flick-Smith,et al.  Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates. , 2007, Microbial pathogenesis.

[51]  R. Titball,et al.  A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. , 1995, Vaccine.